Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to confirm the safety of tolvaptan in patients with hyponatremia in syndrome of inappropriate antidiuretic hormone secretion (SIADH) in Japan


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04790175
Study type Observational
Source Otsuka Pharmaceutical Co., Ltd.
Contact Pharmacovigilance Department Otsuka Pharmaceutical Co., Ltd
Phone +81-6-6943-7722
Email komaniwa.satoshi@otsuka.jp
Status Recruiting
Phase
Start date March 29, 2021
Completion date January 2030